跳至主要内容
临床试验/NCT05524896
NCT05524896已完成不适用

Elucidate Vasodilatory Capacity From Histology-Defined Analysis of Coronary CT Angiography

Elucid Bioimaging Inc.0 个研究点目标入组 302 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
302
主要终点
Sensitivity

研究概览

简要总结

Coronary CT Angiography (CCTA) may be an ideal modality to fill gaps in understanding the extent and rate of progression coronary artery disease. The investigators have developed an image analysis software ElucidVivo that estimates relevant indices, including fractional flow reserve (FFR) . In this study, the investigators aim to assess the value of ElucidVivo-based plaque morphology characterization for predicting non-invasive FFR in patients with suspected coronary artery disease (CAD) who had undergone clinically indicated coronary CTA and invasive coronary angiography (ICA) for physical FFR measurement.

详细描述

Invasive FFR is a clinically validated measure of lesion-specific ischemia and is preferred over visual estimation of diameter stenosis for clinical decisions regarding coronary revascularization. FFR derived from coronary CTA (FFRct) using computational fluid dynamics (CFD)-based software has been shown to be a reasonably accurate estimate of invasive FFR and is included in contemporary guidelines as a decision-tool for management of patients with intermediate stenosis on coronary CTA. However, other methods have limitations. It is understood that the burden and type of coronary atherosclerosis, in addition to lumen stenosis, significantly impacts the vasodilatory capacity of the vessel walls which may provide a more interpretable analysis and broader clinical acceptance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must have successfully completed at least one (possibly multiple) CCTA for known or suspected coronary artery disease.
  • CCTA was no more than 60 days earlier (and not later)

排除标准

  • Subject has a history of percutaneous coronary intervention (PCI) with stent implantation and/or coronary artery bypass grafting (CABG)
  • Subject with insufficient CCTA image quality (defined strictly as documented in the ElucidVivo Reading Manual)

结局指标

主要结局

Sensitivity

时间窗: 1 day

the ability of a test to correctly identify patients with low FFR

Specificity

时间窗: 1 day

the ability of a test to correctly identify people without low FFR

次要结局

  • Average Error(1 day)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

Elucidate Vasodilatory Capacity From... | 临床试验